Author

M. Fresno

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 3 Research Focus:host-pathogen & immune response· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Assay:clinical cohort / trial· 1 Research Focus:development & morphogenesis· 1

Frequent Co-Authors

A. Arranz· 1 shared A. Barbachano· 1 shared A. Jimenez-Segovia· 1 shared A. Mota· 1 shared A. Rojo-Sebastian· 1 shared A. Rynne-Vidal· 1 shared B. Barrocal· 1 shared B. Salvador· 1 shared

Activity by Year

2018-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Arranz

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Anti-inflammatory immunomodulation for the treatment of Congenital Diaphragmatic Hernia

M. Vallejo-Cremade, J. Merino, R. Carmona, L. Cordoba, B. Salvador, L. Martinez, J. A. Tovar, M. A. Llamas, R. Munoz-Chapuli, M. Fresno

This study shows that atypical TLR2/4 ligands can cure congenital diaphragmatic hernia in animal models by promoting M2 macrophage infiltration and retinoic acid pathway activation.

bioRxiv · Nov 7, 2023 · PreprintImmunology

Balance of AKT isoforms in intestinal barrier function. Implications for IBD therapy.

T. Garcia Prieto, A. Barbachano, N. G. Cuesta, D. SANCHEZ GONZALEZ, A. Arranz, M. Fresno

This study shows that balancing Akt1 and Akt2 isoforms regulates intestinal barrier function and inflammation, with Akt2 inhibition improving IBD symptoms in mice.

bioRxiv · Jul 4, 2023 · PreprintImmunology

Prostaglandin F2α-induced TGFβ-PMEPA1 pathway is a critical mediator of epithelial plasticity and ovarian carcinoma progression.

A. Jimenez-Segovia, A. Mota, A. Rojo-Sebastian, B. Barrocal, A. Rynne-Vidal, M. L. Garcia-Bermejo, R. Gomez-Bris, L. J. A. C. Hawinkels, P. Sandoval, R. Garcia-Escudero, M. Lopez-Cabrera, G. Moreno-Bueno, M. Fresno, K. Stamatakis

This paper identifies PGF2α-induced TGFβ-PMEPA1 pathway as a driver of epithelial plasticity and ovarian cancer progression, with PMEPA1 as a therapeutic target and prognostic biomarker.

bioRxiv · Sep 18, 2018Cancer Biology